These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1285097)

  • 1. The epidemiology of pertussis in the Republic of Ireland.
    Howell F; Jennings S
    Commun Dis Rep CDR Rev; 1992 Feb; 2(3):R31-3. PubMed ID: 1285097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
    Matter HC; Schmidt-Schläpfer G; Zimmermann H
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pertussis: a reemerging infection?].
    Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M
    Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1996 pertussis epidemic in New Zealand: descriptive epidemiology.
    Blakely T; Mansoor O; Baker M
    N Z Med J; 1999 Feb; 112(1081):30-3. PubMed ID: 10078212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.
    Kimura M; Kuno-Sakai H
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):263-73. PubMed ID: 3508651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiological situation of pertussis in the Federal Republic of Germany.
    Finger H; Wirsing von König CH; Tacken A; Wassilak SG
    Dev Biol Stand; 1991; 73():343-55. PubMed ID: 1778329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of immunization against pertussis.
    Stuart-Harris C
    Dev Biol Stand; 1979; 43():75-83. PubMed ID: 520687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an accelerated immunisation schedule on pertussis in England and Wales.
    White JM; Fairley CK; Owen D; Matthews RC; Miller E
    Commun Dis Rep CDR Rev; 1996 May; 6(6):R86-91. PubMed ID: 8664929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious disease mortality in two Outer Hebridean islands: 1. measles, pertussis and influenza.
    Clegg EJ
    Ann Hum Biol; 2003; 30(4):455-71. PubMed ID: 12881144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current epidemiology of pertussis in the United States.
    Hutchins SS; Cochi SL; Brink EW; Patriarca PA; Wassilak SG; Rovira EZ; Hinman AR
    Tokai J Exp Clin Med; 1988; 13 Suppl():103-9. PubMed ID: 2856218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis--going, going, but not gone: thirteen year trends in the incidence of pertussis in the Republic of Ireland and North Eastern Health Board.
    Shahdadpuri RI; Nicholson AJ; Bedford D; O'Flanagan D
    Ir Med J; 2004 Feb; 97(2):44-6. PubMed ID: 15134268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.
    Binkin NJ; Salmaso S; Tozzi AE; Scuderi G; Greco D; Greco D
    Pediatr Infect Dis J; 1992 Aug; 11(8):653-61. PubMed ID: 1523078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].
    de Greeff SC; Schellekens JF; Mooi FR; de Melker HE
    Ned Tijdschr Geneeskd; 2005 Apr; 149(17):937-43. PubMed ID: 15884408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of pertussis in England and Wales.
    Miller E; Vurdien JE; White JM
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R152-4. PubMed ID: 1285134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy.
    Rota MC; D'Ancona F; Massari M; Mandolini D; Giammanco A; Carbonari P; Salmaso S; Ciofi degli Atti ML
    Vaccine; 2005 Nov; 23(46-47):5299-305. PubMed ID: 16112254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.